Hongyuan Pharmaceutical: Announcement on Change of Signing Certified Public Accountant
Securities code: 301246 Securities abbreviation: Hongyuan Pharmaceutical Announcement number: 2026-002
Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
Announcement on Change of Signing Certified Public Accountant
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and there are no false records, misleading statements or major omissions.
Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (hereinafter referred to as the "Company") held the 10th meeting of the 4th Board of Directors and the 9th meeting of the 4th Board of Supervisors on April 23, 2025, and held the 2024 Annual General Meeting of Shareholders on May 16, 2025. The "About Renewal of Appointment in 2025" was considered and approved. "Annual Audit Institution's Proposal", agreed to renew the appointment of China Shen Zhonghuan Accounting Firm (Special General Partnership) (hereinafter referred to as "China Shen Zhonghuan") to continue as the company's 2025 annual audit institution, responsible for the company's 2025 annual financial report and internal control audit work. For specific content, please refer to the "Announcement on Renewal of the Audit Institution for 2025" (announcement number: 2025-022) disclosed by the company on April 25, 2025 on the Cninfo Network (www.cninfo.com.cn).
Recently, the company received the "Letter on Changing the Signing Certified Public Accountant of Hubei Hongyuan Pharmaceutical Technology Co., Ltd.'s 2025 Annual Report" issued by Zhongshen Zhonghuan. The specific situation is now announced as follows:
1. The situation of this change of signing CPA
As the company's 2025 annual financial report and internal control audit agency, Li Wei (project partner) and Peng Dongmei were originally appointed as signing certified public accountants to provide audit services for the company. Due to the adjustment of work within the firm, Peng Dongmei is now replaced by Fang Mengyuan to provide the company with audit services for 2025 and continue to complete relevant work. The signing CPAs after this change are Li Wei and Fang Mengyuan.
2. Basic information and integrity and independence of the certified public accountant who signed this change
- Basic information
Fang Mengyuan, the certified public accountant who signed this change, became a Chinese certified public accountant in 2021. He has been engaged in the audit of listed companies since 2014, and has been practicing at Zhongshen Zhonghuan since 2012. He will start providing audit services to the company in 2025. In the past three years, 0 companies have signed audit reports for listed companies.
- Integrity record
Fang Mengyuan, the certified public accountant who signed this change, has not been subject to administrative penalties or supervisory measures by the China Securities Regulatory Commission, its dispatched agencies, industry authorities, etc., nor has she been subject to self-regulatory measures or disciplinary sanctions by self-regulatory organizations such as stock exchanges and industry associations in the past three years.
- Independence
Fang Mengyuan did not violate the independence requirements of the Chinese Code of Professional Ethics for Certified Public Accountants.
3. Other instructions
The relevant work involved in this change of signing accountant has been handed over in an orderly manner and will not have an adverse impact on the audit of the company's 2025 financial statements.
4. Documents for reference
"Letter on Changing the Signing Certified Public Accountant for the 2025 Annual Report of Hubei Hongyuan Pharmaceutical Technology Co., Ltd." issued by Zhongshen Zhonghuan Accounting Firm (Special General Partnership);
The identity document, practice license and contact information of the signed certified public accountant for this change.
Announcement is hereby made.
Board of Directors of Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
January 20, 2026